Successful downstream blockade of TERTp activity via E26 transformation-specific (ETS) transcription factor inhibition is a potential therapeutic strategy for these tumors.57,58 Other rare mutations associated with higher-grade meningiomas include ARID1A, PTEN, and PBRM1. The gene discussed is PBRM1; the disease is meningioma.